Download presentation
Presentation is loading. Please wait.
Published byMichael Young Modified over 8 years ago
1
Croda International Plc Results for 6 months to 30 June 2003
2
Summary 3% volume growth in Personal and Health Care sales Margins strong £8m reduction in debt to £43.7m
3
Summary of continuing operations Sales150.1151.4 Operating profit22.321.6 Interest(1.7)(2.3) Profit before tax 20.619.3 20032002 £m £m
4
Statistics 2003 2002 EPS normalised (p)9.99.3 DPS (p)4.023.91 Interest cover (x)12.89.3 Tax rate (%)35.535.9
5
Sales by destination* 2003 2002 £m%£m% United Kingdom22.91525.117 Rest of Europe48.83340.227 Americas45.63052.134 Asia19.31320.213 Rest of World13.5913.89 ______________ 150.1100151.4100 ______________________________ * continuing operations only
6
Sales by market* Personal & Health Care83.75682.955 Home Care & Plastics Additives21.51422.415 Industrial Specialities28.21928.018 Other16.71118.112 _________ ________ ________ ________ 150.1100 151.4100 _________ ________ ________ ________ * continuing operations only 20032002 £m% £m %
7
Turnover change on prior year* Volume Currency Mix/ Total price Group- 7.0%- 2.0%+ 8.0%- 1.0% * continuing operations only
8
Value/volume change on prior year* % ofValueVolume Sales % % 56Personal & Health Care +1 +3 14Home Care and Plastics Additives - 4 -13 19Industrial Specialities + 1 + 1 11Other - 8 - 17 ________ 100 _________ * continuing operations only
9
Oleochemicals trading margin* * continuing operations only
10
Cash flow £m 20032002 Operating cash flow25.720.8 Interest(1.7)(2.3) Dividends(4.5)(4.2) Taxation(7.0)(6.9) _______ _______ Free cash flow12.57.4 Net Capex(4.4)(8.4) Own shares(0.6)(0.3) Disposals/Acquisitions/Closures (0.4)0.1 _______ _______ Net cash flow7.1(1.2) Other1.31.5 _______ _______ Reduction in net debt8.40.3 _______ _______
11
Summary of trading Personal and Health Care driving growth Positive price/mix effect USA a little slower Europe stronger
12
Business development
13
New Personal Care products Unislim Lumiskin Stevia
14
Silhouette Sculptor for men and women UNISLIM TM
15
UNISLIM Complex of 2 plants with slimming properties Green coffee (Cafestol + Kahweol) Yerba Mate (Methyl-xanthine)
16
UNISLIM : 2-way active Lipolysis Activation Decrease of lipid entry Phosphodiesterase inhibition Presence of lipid receptors on the cell membrane DESTOCKING BLOCKS THE LIPID STORAGE Green coffeeYerba Mate
17
Average reduction: 0,8 cm Up to 1,9 cm Women’s Thighs perimeter BeforeAfter
18
Men’s Volume of folds of fat -17,7 cm 3
19
Lumiskin LUMISKIN give fairness to your skin
20
Control566ppm Kojic Acid25ppm DAB Inhibition of tyrosinase activity and melanin production on B16 cells IN VITRO Lumiskin
21
SkinEthic 3D model of epidermis type VI EX VIVO Cross sections Control Lumiskin 1.25% Lumiskin 4% Lumiskin
22
COLORIMETRIC TEST ON PIGMENTATION SPOTS IN VIVO Before Lumiskin After Before
23
Stevia Stevia rebaudiana From Brazil and Paraguay Skin moisturiser Emollient
24
+ 14 % Moisturising Effect Stevia
25
Health Care Provensis update Natural asthma treatment launched H1 2003 Crohn’s disease - Phase III clinicals
26
Outlook Personal Care strong growth Health Care continues to progress Price increases holding Strong product pipeline
Similar presentations
© 2025 SlidePlayer.com. Inc.
All rights reserved.